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Objective: Our aim in this study is to clarify the clinical and pathologic
features of small peripheral adenocarcinoma of the lung with special
emphasis on intraoperative identification of lymph node metastasis. Pa-
tients and methods: Between 1980 and 1996, 157 patients underwent lobec-
tomy and complete hilar/mediastinal lymphadenectomy for small (1.1 to 2.0
cm in diameter) peripheral adenocarcinoma of the lung. The intraoperative
assessment, the distribution of metastatic lymph nodes, and the association
between the tumor’s histopathologic characteristics and lymph node me-
tastasis were retrospectively investigated in this study. Results: Postopera-
tive examination revealed lymph node metastasis in 27 (17%) patients.
Lymph node metastases were not noticed during the operation in 19 of
these 27 patients. Metastases were localized in single lymph nodes in 10
patients; the metastates were distributed over a segmental, a lobar, an
interlobar, and a mediastinal lymph node. The prevalence of lymph node
metastasis was as follows: Of 92 patients with well-differentiated adenocar-
cinoma, seven (8%) had lymph node metastases; of the 65 patients with
other types of tumors, 20 (31%) had lymph node metastases. Of 120
patients without pleural involvement, 13 (11%) had lymph node metastases;
of the 37 with pleural involvement, 14 (38%) had lymph node metastases.
Five-year survivals were estimated at 91% 6 6% (mean 6 95% confidence
interval) for 130 patients with N0 tumor and 30% 6 22% for 27 patients
with N1 or N2 tumor. Conclusions: Intraoperative assessment is not reliable
for identifying lymph node metastasis. Lobectomy and complete hilar/
mediastinal lymphadenectomy are necessary to determine N stage rigidly.
Histologic degree of differentiation and pleural involvement are signifi-
cantly associated with lymph node metastasis. (J Thorac Cardiovasc Surg
1998;116:276-80)
The extent of resection has been discussed forsmall peripheral carcinomas of the lung,1-4 be-
cause these tumors were regarded as possibly being
amenable to lesser resections (segmentectomy and
wedge resection) than lobectomy. Lobar and seg-
mental lymph nodes are not removed with lesser
resections, whereas they are removed with lobec-
tomy. Nodal status is assessed with computed to-
mography5 or mediastinoscopy6 before the opera-
tion. Mediastinal and hilar lymph nodes are
explored during the operation by a surgeon. If
necessary, a few lymph nodes are sampled and
examined pathologically to determine whether they
are positive or negative for tumor. However, can all
patients with lymph node metastasis be identified
before or during the operation? Adenocarcinoma is
the most common histologic type of small peripheral
lung carcinomas. And adenocarcinoma has consid-
erable potential for lymph node metastasis, even
small adenocarcinomas 2 cm or less in diameter.7, 8
In this retrospective study, we intended to clarify
clinical and pathologic features of small peripheral
adenocarcinoma of the lung with special emphasis
on lymph node metastasis.
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Patients and methods
Patients. Between January 1980 and December 1996,
789 patients with clinical stage I peripheral lung cancer
underwent lobectomy and complete hilar/mediastinal
lymphadenectomy at our hospital. Among them, 157
patients had small-sized adenocarcinomas that ranged
from 1.1 to 2.0 cm in maximum diameter; these patients
formed the study group for this retrospective investigation
(Table I).
Assessment of nodal status. Mediastinal and hilar
lymph nodes were measured through a computed tomo-
graphic scan of the thorax before thoracotomy. Lymph
nodes were l cm or less in short-axis diameter in each
patient, a size that was considered to be within the normal
limits. Mediastinoscopy was not used. Lobectomy and
complete hilar/mediastinal lymphadenectomy were per-
formed as previously described.9 The surgeon reported
the intraoperative assessment for lymph node metastasis
immediately after the operation. All lymph nodes were
arranged by the surgeon according to the mapping of the
American Thoracic Society.10 Each lymph node was ex-
amined pathologically and classified as positive or nega-
tive for tumor.
Histopathologic characteristics of the tumors. Tumors
were subgrouped into well-differentiated, moderately dif-
ferentiated, and poorly differentiated adenocarcinoma
according to the World Health Organization classification
of lung tumors.11 Positive pleural involvement was defined
as extension of the tumor beyond the elastic layer of the
visceral pleura. Pathologic stage was determined accord-
ing to the new international staging system.12 T stage was
upstaged to T2 when tumor was exposed on the pleural
surface and to T3 when tumor invaded the parietal pleura.
Statistical analysis. The prevalence of lymph node
metastasis was evaluated in the category of patient vari-
ables (age, sex), tumor size, the degree of differentiation,
or the pleural involvement. Univariate analysis of the
categoric data was performed using 2 3 2 contingency x2
with Yates’ correction for continuity. To further clarify the
independent factors association with lymph node metas-
tasis, we performed a multiple logistic regression analysis
using the SAS software package (Statistical Analysis Sys-
tems, Inc., Cary, N.C.). Postoperative survivals were cal-
culated by the Kaplan-Meier method. The median fol-
low-up period was 1989 days and ranged from 84 to 5511
days. A total of 119 patients were observed for a minimum
of 5 postoperative years or until death. Thirty-eight pa-
tients were censored according to the Kaplan-Meier
method because their follow-up periods were less than 5
years. The statistical difference of survivals was examined
by means of the log-rank test.
Results
Postoperative examination revealed lymph node
metastasis in 27 (17%) patients. Table II shows the
number of examined nodes, the intraoperative as-
sessment for lymph node metastasis, and the distri-
bution of metastatic lymph nodes. Eleven patients
(cases 1 to 11) had N1 metastases. Sixteen patients
had N2 metastases (cases 12 to 27). Lymph node
metastases were noticed during the operation in
eight patients (cases 8, 12, 14, 16, 18, 19, 22, and 25),
but they were not noticed during the operation in 19
of 27 patients (70%). Metastases were localized at
single lymph nodes in 10 cases: a segmental node in
the one (case 1), a lobar node in the five (cases 2 to
6), a interlobar node in two (cases 9 and 10), a
pretracheal node in one (case 19), and a highest
mediastinal node in one (case 24). Table III shows
the prevalence of lymph node metastasis and the
results of univariate analysis for patient variables
(age, sex), tumor size, histologic degree of differen-
tiation, or pleural involvement. On univariate anal-
ysis, histologic degree of differentiation and pleural
involvement were significantly associated with
lymph node metastasis. Table IV shows the result of
multiple logistic regression analysis. Sex, histologic
degree of differentiation, and pleural involvement
were significantly associated with lymph node me-
tastasis. The postoperative survival curves are shown
in Fig. 1. Five-year survival was estimated at 91% 6
6% (mean 6 95% confidence interval) for 130
patients with N0 tumor. Five-year survival was esti-
mated at 28% 6 22% for 27 patients with N1 or N2
tumor. Statistically significant difference was ob-
served between patients with N0 tumor and those
with N1 or N2 tumor (p 5 0.0000).
Discussion
Can all patients with lymph node metastasis be
identified in the preoperative or intraoperative pe-
Table I. Characteristics of 157 patients with small
peripheral adenocarcinoma of the lung
No. %
Sex
Male 75 47
Female 82 53
Age (yr)
Range 29–85
Median 64
Tumor size (cm)
Range 1.1–2.0
Median 1.7
T stage
T1 143 91
T2 13 8
T3 1 1
N stage
N0 130 83
N1 11 7
N2 16 10
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riod? In this study, computed tomographic scan
falsely predicted negative nodal involvement in 17%
of patients with small peripheral adenocarcinoma of
the lung. The surgeons could not detect metastases
in 70% of patients with nodal involvement. Metas-
tases were localized at single lymph nodes in 37% of
patients with nodal involvement; these single nodal
metastases were distributed over a segmental, a
lobar, a hilar, and a mediastinal lymph node. These
observations suggest that it is almost impossible to
identify all lymph node metastasis before or during
the operation. Lobar and segmental lymph nodes,
which are removed with lobectomy, remain unre-
moved with lesser resections. Microscopic metasta-
ses possibly exist in these lymph nodes if lymph node
metastasis is not identified before or during the
operation. This may be one reason that the inci-
dence of local recurrence was significantly higher in
lesser resections (segmentectomy and wedge resec-
tion) than in lobectomy.2-4
A few authors report that several histopathologic
characteristics of small adenocarcinoma are associ-
ated with postoperative prognosis.7, 13, 14 Both histo-
logic degree of differentiation and pleural involve-
ment were significantly associated with lymph node
metastasis in this study. Preoperative or intraoper-
Table II. The intraoperative assessment and the distribution of metastatic lymph nodes
Case No. of nodes IA
Lymph node station
1 2 3 4 5 6 7 8 9 10 11 12 13
1 16 N 1
2 22 N 1
3 13 N 1
4 17 N 1
5 12 N 1
6 20 N 1
7 27 N 1 2
8 30 P 2 1
9 11 N 1
10 13 N 1
11 11 N 1 1
12 19 P 1 1
13 39 N 2 1 2
14 22 P 1 1
15 14 N 1 1 2 1
16 12 P 2 2 1
17 26 N 2 1 1
18 19 P 1 1 2
19 24 P 1
20 9 N 1 1 1 1 1
21 24 N 2 1
22 56 P 5 2
23 25 N 1 1 1
24 15 N 1
25 25 P 2 4 4 1
26 13 N 2 1 1 1 1
27 26 N 2 1 2 4 1
No. of nodes, Number of nodes examined; IA, intraoperative assessment; N, negative for tumor; P, positive for tumor. Lymph node stations are numbered
according to the American Thoracic Society. A figure in the column of lymph node stations is the number of metastatic lymph nodes.
Table III. Prevalence of lymph node metastasis and
results of univariate analyses
Factors Prevalence % p Value
Age (yr)
29–63 14/77 18 0.912
64–85 13/80 16
Sex
Male 11/75 15 0.553
Female 16/82 20
Tumor size (cm)
1.1–1.5 6/43 14 0.6702
1.6–2.0 21/114 18
Degree of differentiation
Well differentiated 7/92 8 0.0004
Other 20/65 31
Pleural involvement
Negative 13/120 11 0.0004
Positive 14/37 38
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ative identification of these histopathologic charac-
teristics will help surgeons to assess lymph node
metastasis and to decide the extent of resection or
lymphadenectomy for patients in the poor-risk cat-
egory. Postoperative 5-year survival is estimated to
be high (91% 6 6%) for patients with N0 tumor,
although it is estimated to be low (30% 6 22%) for
patients with N1 or N2 tumor. This observation
indicates that N stage is rigidly determined in our
patients who underwent lobectomy and complete
hilar/mediastinal lymphadenectomy.
In conclusion, intraoperative assessment is not
reliable for identifying lymph node metastasis in
small peripheral adenocarcinoma of the lung. Lo-
bectomy and complete hilar/mediastinal lymphade-
nectomy are necessary to determine N stage rigidly.
Histologic degree of differentiation and pleural in-
volvement are associated with lymph node metasta-
sis.
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